Community Oncology Podcast - Axitinib and sorafenib in advanced renal cell carcinoma.
July 31, 2012|The Journal of Community and Supportive Oncology
Author and Disclosure Information
Editor-in-Chief Dr. David H. Henry takes you on an audio tour of the July issue including discussions of an original research report on the impact of depression on cancer comorbidity and this month's Community Translation: Axitinib and sorafenib in second-line treatment of advanced renal cell carcinoma.
